Tarsus Pharmaceuticals, Inc. TARS
68.60 USD +1.08 (+1.60%)
At closeNov 6, 2026, 5:48 PM EST
70.00 +1.40 +2.04%
After hours · Nov 6, 5:48 PM ET
66.53 Day range 69.04
56.11 52-week range 90.78
- YTD
- -16.22%
- 1 year
- +0.75%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 451.36M | 182.95M | 17.45M | 25.82M | 57.03M | |
| 420.68M | 170.13M | 15.85M | 24.86M | 54.95M | |
| -70.97M | -120.57M | -143.16M | -62.71M | -12.16M | |
| -66.42M | -115.55M | -135.89M | -62.09M | -13.83M | |
| -1.59 | -3.07 | -4.62 | -2.52 | -0.67 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 184.20M | 94.82M | 224.95M | 71.66M | 171.33M | |
| 562.16M | 376.99M | 265.49M | 227.86M | 178.91M | |
| 218.73M | 152.46M | 68.50M | 34.96M | 12.18M | |
| 72.44M | 71.84M | 29.82M | 19.43M | 0 | |
| 343.43M | 224.53M | 196.99M | 192.90M | 166.73M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -12.45M | -83.03M | -117.49M | -49.03M | 3.75M | |
| -42.12M | -199.19M | 140.60M | -144.63M | -586.00K | |
| 143.39M | 154.66M | 130.18M | 93.99M | 21.00K | |
| -9.86M | -6.57M | -5.50M | -506.00K | -586.00K | |
| 88.82M | -127.57M | 153.29M | -99.67M | 3.18M |